Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Histone modifier gene mutations in peripheral T-cell lymphoma not otherwise specified.

Haematologica - 1 Apr 2018

Ji Meng-Meng, Huang Yao-Hui, Huang Jin-Yan, Wang Zhao-Fu, Fu Di, Liu Han, Liu Feng, Leboeuf Christophe, Wang Li, Ye Jing, Lu Yi-Ming, Janin Anne, Cheng Shu, Zhao Wei-Li

Abstract excerpt

Due to heterogeneous morphological and immunophenotypic features, approximately 50% of peripheral T-cell lymphomas are unclassifiable and categorized as peripheral T-cell lymphomas, not otherwise specified. These conditions have an aggressive course and poor clinical outcome. Identification of actionable biomarkers is urgently needed to develop better therapeutic strategies. Epigenetic alterations play a crucial...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acetylation
Share to Aminopyridines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Benzamides

Share to Decitabine

Share to Genes, Modifier

Share to Heterografts

Share to Lymphoma, T-Cell, Peripheral

Share to Methylation

Source

Open in PubMed Open full text

Identifiers

PMID: 29305415
DOI: 10.3324/haematol.2017.182444
PMCID: PMC5865443

Genes

CREBBP
SETD2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Histone modifier gene mutations in peripheral T-cell lymphoma not otherwise specified.PMID 29305415Read ↗

Mutation of chromatin modifiers; an emerging hallmark of germinal center B-cell lymphomas.Semantic proximity Read ↗

CREBBP/EP300 mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-associated macrophage polarization via FBXW7-NOTCH-CCL2/CSF1 axisSemantic proximity Read ↗

Histone Modifications and Their Targeting in Lymphoid MalignanciesSemantic proximity Read ↗

Follicular lymphoma, a B cell malignancy addicted to epigenetic mutations.Semantic proximity Read ↗

Frequent Mutations in Natural Killer/T Cell Lymphoma.Semantic proximity Read ↗

Epigenetic Mechanisms of Therapy Resistance in Diffuse Large B Cell Lymphoma (DLBCL).Semantic proximity Read ↗

Methylation alterations and advance of treatment in lymphomaSemantic proximity Read ↗

Gene mutations in malignant lymphoma.Semantic proximity Read ↗

Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profilingSemantic proximity Read ↗

Genomic complexity is associated with epigenetic regulator mutations and poor prognosis in diffuse large B-cell lymphoma.Semantic proximity Read ↗

Epigenetic alterations and advancement of treatment in peripheral T-cell lymphoma.Semantic proximity Read ↗

Targeting epigenetic regulators in the treatment of T-cell lymphoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.